[RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells].
Identifieur interne : 001017 ( Ncbi/Merge ); précédent : 001016; suivant : 001018[RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells].
Auteurs : Xu-Dong Zhu [République populaire de Chine] ; Ying Dang ; Yi Feng ; Tao Li ; Pei-Tang HuangSource :
- Sheng wu gong cheng xue bao = Chinese journal of biotechnology [ 1000-3061 ] ; 2004.
Descripteurs français
- KwdFr :
- MESH :
- génétique : Petit ARN interférent, Virus du SRAS.
- métabolisme : ARN messager, ARN viral.
- physiologie : Ribonuclease III.
- Cellules cultivées, Humains, Interférence par ARN, Plasmides.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : RNA, Small Interfering.
- chemical , metabolism : RNA, Messenger, RNA, Viral.
- chemical , physiology : Ribonuclease III.
- genetics : SARS Virus.
- Cells, Cultured, Humans, Plasmids, RNA Interference.
Abstract
SARS-associated coronavirus has been identified for the cause of Severe Acute Respiratory Syndrome, for which there is no efficacious drugs or vaccines. RNA interference (RNAi) is a process in cell to degradation specific target mRNA by double-stranded RNA. In mammalian cells, RNAi can be triggered by short interfering RNA (siRNA). RNA interference of virus-specific genes has emerged as a potential antiviral mechanism. This work evaluated if RNase III-prepared short interfering RNAs can induce specific degradation of SARS-coronavirus mRNAs in human cells. Three of SARS genes, RNA dependent RNA polymerase (RdRp), spike and nucleocapsid, were amplified with T7 promoter-flanked primers. Long length double-stranded RNA of these genes were transcribed in vitro and then were cleaved to <30bp length short interfering RNA with E. coli RNase III. These siRNAs were termed esiRNA-R, esiRNA-S and esiRNA-N respectively. RdRp, spike and nucleocapsid DNA fragments were inserted into the plasmid pGL3-Control, obtained plasmids pGL-R, pGL-S and pGL-N can express hybrid mRNAs luciferase-RdRp, spike and -nucleocapsid in cells. Above plasmids and esiRNAs were co-transfected to HEK293F cells with reference plasmid pRL-TK. Firefly luciferase and Renilla luciferase activity were measured. Hybrid mRNAs' abundance was measured using reverse transcription real-time PCR. Firefly luciferase expression of pGL-R was reduced to 13% by esiRNA-R. Expression of pGLS was reduced to 11% by esiRNA-S. Expression of pGL-N was reduced to 40% by esiRNA-N. Control esiRNAs didn't affect luciferase expression; Hybrid mRNAs' abundance was dramatically reduced by corresponding esiRNAs. RNase III-prepared short interfering RNAs induce robust and specific degradation of SARS-coronavirus mRNAs in HEK293F cells. These siRNAs could be used to inhibit SARS-coronavirus in future research.
PubMed: 15968975
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002679
- to stream PubMed, to step Curation: 002679
- to stream PubMed, to step Checkpoint: 002893
Links to Exploration step
pubmed:15968975Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells].</title>
<author><name sortKey="Zhu, Xu Dong" sort="Zhu, Xu Dong" uniqKey="Zhu X" first="Xu-Dong" last="Zhu">Xu-Dong Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>Beijing Institute of Biotechnology, Beijing 100071, China. xd_zhu@263.net</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Beijing Institute of Biotechnology, Beijing 100071</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dang, Ying" sort="Dang, Ying" uniqKey="Dang Y" first="Ying" last="Dang">Ying Dang</name>
</author>
<author><name sortKey="Feng, Yi" sort="Feng, Yi" uniqKey="Feng Y" first="Yi" last="Feng">Yi Feng</name>
</author>
<author><name sortKey="Li, Tao" sort="Li, Tao" uniqKey="Li T" first="Tao" last="Li">Tao Li</name>
</author>
<author><name sortKey="Huang, Pei Tang" sort="Huang, Pei Tang" uniqKey="Huang P" first="Pei-Tang" last="Huang">Pei-Tang Huang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15968975</idno>
<idno type="pmid">15968975</idno>
<idno type="wicri:Area/PubMed/Corpus">002679</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002679</idno>
<idno type="wicri:Area/PubMed/Curation">002679</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002679</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002893</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002893</idno>
<idno type="wicri:Area/Ncbi/Merge">001017</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells].</title>
<author><name sortKey="Zhu, Xu Dong" sort="Zhu, Xu Dong" uniqKey="Zhu X" first="Xu-Dong" last="Zhu">Xu-Dong Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>Beijing Institute of Biotechnology, Beijing 100071, China. xd_zhu@263.net</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Beijing Institute of Biotechnology, Beijing 100071</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dang, Ying" sort="Dang, Ying" uniqKey="Dang Y" first="Ying" last="Dang">Ying Dang</name>
</author>
<author><name sortKey="Feng, Yi" sort="Feng, Yi" uniqKey="Feng Y" first="Yi" last="Feng">Yi Feng</name>
</author>
<author><name sortKey="Li, Tao" sort="Li, Tao" uniqKey="Li T" first="Tao" last="Li">Tao Li</name>
</author>
<author><name sortKey="Huang, Pei Tang" sort="Huang, Pei Tang" uniqKey="Huang P" first="Pei-Tang" last="Huang">Pei-Tang Huang</name>
</author>
</analytic>
<series><title level="j">Sheng wu gong cheng xue bao = Chinese journal of biotechnology</title>
<idno type="ISSN">1000-3061</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cells, Cultured</term>
<term>Humans</term>
<term>Plasmids</term>
<term>RNA Interference</term>
<term>RNA, Messenger (metabolism)</term>
<term>RNA, Small Interfering (genetics)</term>
<term>RNA, Viral (metabolism)</term>
<term>Ribonuclease III (physiology)</term>
<term>SARS Virus (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN messager (métabolisme)</term>
<term>ARN viral (métabolisme)</term>
<term>Cellules cultivées</term>
<term>Humains</term>
<term>Interférence par ARN</term>
<term>Petit ARN interférent (génétique)</term>
<term>Plasmides</term>
<term>Ribonuclease III (physiologie)</term>
<term>Virus du SRAS (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>RNA, Small Interfering</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>RNA, Messenger</term>
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Ribonuclease III</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Petit ARN interférent</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>ARN messager</term>
<term>ARN viral</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Ribonuclease III</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cells, Cultured</term>
<term>Humans</term>
<term>Plasmids</term>
<term>RNA Interference</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cellules cultivées</term>
<term>Humains</term>
<term>Interférence par ARN</term>
<term>Plasmides</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">SARS-associated coronavirus has been identified for the cause of Severe Acute Respiratory Syndrome, for which there is no efficacious drugs or vaccines. RNA interference (RNAi) is a process in cell to degradation specific target mRNA by double-stranded RNA. In mammalian cells, RNAi can be triggered by short interfering RNA (siRNA). RNA interference of virus-specific genes has emerged as a potential antiviral mechanism. This work evaluated if RNase III-prepared short interfering RNAs can induce specific degradation of SARS-coronavirus mRNAs in human cells. Three of SARS genes, RNA dependent RNA polymerase (RdRp), spike and nucleocapsid, were amplified with T7 promoter-flanked primers. Long length double-stranded RNA of these genes were transcribed in vitro and then were cleaved to <30bp length short interfering RNA with E. coli RNase III. These siRNAs were termed esiRNA-R, esiRNA-S and esiRNA-N respectively. RdRp, spike and nucleocapsid DNA fragments were inserted into the plasmid pGL3-Control, obtained plasmids pGL-R, pGL-S and pGL-N can express hybrid mRNAs luciferase-RdRp, spike and -nucleocapsid in cells. Above plasmids and esiRNAs were co-transfected to HEK293F cells with reference plasmid pRL-TK. Firefly luciferase and Renilla luciferase activity were measured. Hybrid mRNAs' abundance was measured using reverse transcription real-time PCR. Firefly luciferase expression of pGL-R was reduced to 13% by esiRNA-R. Expression of pGLS was reduced to 11% by esiRNA-S. Expression of pGL-N was reduced to 40% by esiRNA-N. Control esiRNAs didn't affect luciferase expression; Hybrid mRNAs' abundance was dramatically reduced by corresponding esiRNAs. RNase III-prepared short interfering RNAs induce robust and specific degradation of SARS-coronavirus mRNAs in HEK293F cells. These siRNAs could be used to inhibit SARS-coronavirus in future research.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15968975</PMID>
<DateCompleted><Year>2010</Year>
<Month>04</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2005</Year>
<Month>06</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1000-3061</ISSN>
<JournalIssue CitedMedium="Print"><Volume>20</Volume>
<Issue>4</Issue>
<PubDate><Year>2004</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Sheng wu gong cheng xue bao = Chinese journal of biotechnology</Title>
<ISOAbbreviation>Sheng Wu Gong Cheng Xue Bao</ISOAbbreviation>
</Journal>
<ArticleTitle>[RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells].</ArticleTitle>
<Pagination><MedlinePgn>484-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>SARS-associated coronavirus has been identified for the cause of Severe Acute Respiratory Syndrome, for which there is no efficacious drugs or vaccines. RNA interference (RNAi) is a process in cell to degradation specific target mRNA by double-stranded RNA. In mammalian cells, RNAi can be triggered by short interfering RNA (siRNA). RNA interference of virus-specific genes has emerged as a potential antiviral mechanism. This work evaluated if RNase III-prepared short interfering RNAs can induce specific degradation of SARS-coronavirus mRNAs in human cells. Three of SARS genes, RNA dependent RNA polymerase (RdRp), spike and nucleocapsid, were amplified with T7 promoter-flanked primers. Long length double-stranded RNA of these genes were transcribed in vitro and then were cleaved to <30bp length short interfering RNA with E. coli RNase III. These siRNAs were termed esiRNA-R, esiRNA-S and esiRNA-N respectively. RdRp, spike and nucleocapsid DNA fragments were inserted into the plasmid pGL3-Control, obtained plasmids pGL-R, pGL-S and pGL-N can express hybrid mRNAs luciferase-RdRp, spike and -nucleocapsid in cells. Above plasmids and esiRNAs were co-transfected to HEK293F cells with reference plasmid pRL-TK. Firefly luciferase and Renilla luciferase activity were measured. Hybrid mRNAs' abundance was measured using reverse transcription real-time PCR. Firefly luciferase expression of pGL-R was reduced to 13% by esiRNA-R. Expression of pGLS was reduced to 11% by esiRNA-S. Expression of pGL-N was reduced to 40% by esiRNA-N. Control esiRNAs didn't affect luciferase expression; Hybrid mRNAs' abundance was dramatically reduced by corresponding esiRNAs. RNase III-prepared short interfering RNAs induce robust and specific degradation of SARS-coronavirus mRNAs in HEK293F cells. These siRNAs could be used to inhibit SARS-coronavirus in future research.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName>
<ForeName>Xu-Dong</ForeName>
<Initials>XD</Initials>
<AffiliationInfo><Affiliation>Beijing Institute of Biotechnology, Beijing 100071, China. xd_zhu@263.net</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dang</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Feng</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Tao</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Pei-Tang</ForeName>
<Initials>PT</Initials>
</Author>
</AuthorList>
<Language>chi</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>China</Country>
<MedlineTA>Sheng Wu Gong Cheng Xue Bao</MedlineTA>
<NlmUniqueID>9426463</NlmUniqueID>
<ISSNLinking>1000-3061</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.1.26.3</RegistryNumber>
<NameOfSubstance UI="D043244">Ribonuclease III</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D043244" MajorTopicYN="N">Ribonuclease III</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>4</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15968975</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Dang, Ying" sort="Dang, Ying" uniqKey="Dang Y" first="Ying" last="Dang">Ying Dang</name>
<name sortKey="Feng, Yi" sort="Feng, Yi" uniqKey="Feng Y" first="Yi" last="Feng">Yi Feng</name>
<name sortKey="Huang, Pei Tang" sort="Huang, Pei Tang" uniqKey="Huang P" first="Pei-Tang" last="Huang">Pei-Tang Huang</name>
<name sortKey="Li, Tao" sort="Li, Tao" uniqKey="Li T" first="Tao" last="Li">Tao Li</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Zhu, Xu Dong" sort="Zhu, Xu Dong" uniqKey="Zhu X" first="Xu-Dong" last="Zhu">Xu-Dong Zhu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001017 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001017 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:15968975 |texte= [RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15968975" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |